Filing Flows › Comparisons › JNJ vs LLY
Johnson & Johnson vs ELI Lilly: JNJ and LLY compared
Johnson & Johnson is the larger company: $25.4B of revenue in its latest quarter (Q3 2026) against $24.4B for ELI Lilly (Q3 2026). ELI Lilly is growing faster (+39% against +6% a year earlier). ELI Lilly is more profitable, with an operating margin of 34.5% against 0.1%.
Where the money goes: JNJ and LLY
Johnson & Johnson (JNJ) · Q3 2026
Johnson & Johnson, Q3 2026: revenue $25.4B (+6% year over year), operating margin 0.1%, net earnings $210M, operating cash flow $7.7B. The chart follows the revenue to costs, profit and cash.
ELI Lilly (LLY) · Q3 2026
ELI Lilly, Q3 2026: revenue $24.4B (+39% year over year), operating margin 34.5%, net earnings $6.5B, operating cash flow $11.4B. The chart follows the revenue to costs, profit and cash.
| Johnson & Johnson (JNJ) | ELI Lilly (LLY) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $25.4B | $24.4B |
| Revenue growth, Y/Y | +6% | +39% |
| Gross margin | 68.1% | — |
| Operating margin | 0.1% | 34.5% |
| Net earnings | $210M | $6.5B |
| Net margin | 0.8% | 26.4% |
| Operating cash flow | $7.7B | $11.4B |
| Free cash flow | $6.4B | $8.2B |
| Market value | $676.4B | $1.22T |
| P/E | 42.0× | 44.3× |
| Analysts’ mean target | $279.41 | $1453.40 |
Where the revenue comes from
Johnson & Johnson
- Innovative Medicine: $16.8B (66%)
- MEDTECH: $8.6B (34%)
ELI Lilly
- Net product revenue: $22.7B (93%)
- Other oncology: $1.1B (4%)
- Other immunology: $579M (2%)
Questions
Which is bigger, Johnson & Johnson or ELI Lilly?
Johnson & Johnson is the larger company: $25.4B of revenue in its latest quarter (Q3 2026) against $24.4B for ELI Lilly (Q3 2026).
Is Johnson & Johnson or ELI Lilly growing faster?
ELI Lilly is growing faster (+39% against +6% a year earlier).
Which is more profitable, Johnson & Johnson or ELI Lilly?
ELI Lilly is more profitable, with an operating margin of 34.5% against 0.1%.
More: Johnson & Johnson earnings · how Johnson & Johnson makes money · ELI Lilly earnings · how ELI Lilly makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 21, 2026; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.